SEATTLE, WA -- September 7, 2023 -- InvestorsHub NewsWire
-- CBDW AI, a brand of 1606 Corp. (OTC:
CBDW) and the new prominent provider of enterprise-level
artificial intelligence (AI) solutions tailored for the CBD
industry, is thrilled to reveal its strategic partnership with AR
XTLabs, a leading backend development firm. The collaboration aims
to construct an advanced AI Natural Language Processing (NLP)
Chatbot, specially designed for the CBD sector.
The CBDW AI product is being strategically engineered to elevate
customer interactions, deliver an educational resource, facilitate
new customer engagement, and offer CBD product recommendations. The
primary objective of the CBDW AI is to bolster sales for CBD
industry enterprises while ensuring an immensely enjoyable customer
journey.
CBDW AI's strategic vision includes licensing this technology
within the United States to CBD brands and retailers.
The innovative AI project in development leverages the power of
NLP, integrating computational linguistics (CL), machine learning,
and deep learning models to comprehensively analyze human language.
It promises to empower CBD consumers by assisting them in making
informed product decisions based on their queries concerning CBD
usage requirements. Over the years, CBD consumers have often faced
uncertainty when navigating the plethora of choices and their
perceived lack of knowledge about CBD usage. The CBDW AI solution
is poised to address and resolve these long-standing customer
choice issues, making the process of buying CBD products
significantly more consumer-friendly.
"This is a new day for CBDW AI. We're expanding our reach in the
CBD industry to include enterprise customer service solutions for
the growing number of online CBD consumers and brands. For a long
time, choosing products online has always been difficult for CBD
consumers and we aim to solve that problem with our new AI Customer
experience Chatbot. This bot is a game changer for the entire
industry because of the fragmentation of the industry. There are so
many product choices that it's daunting for consumers to make a
choice. In leu of FDA approval, we aim to provide customers with a
high degree of confidence when choosing CBD products," said Greg
Lambrecht, CEO of 1606 Corp.
About AR XTLabs;
AR XTLabs, a new jersey Corporation, is a world leader in
developing AI-enabled products and services for enterprise
customers. Founded in the cloud era, our solutions are cloud-native
and are capable of running on all three major cloud providers. The
solutions we offer have been implemented in Fortune 100 companies
across the Financial Services, Digital media, High-tech, Telecom,
and Pharma sectors. The AR XTLabs team consists of serial
entrepreneurs and experienced professionals who have successfully
implemented an AI-Enabled mortgage closing process in partnership
with a national title insurance company. AR XTLabs has offices in
Seattle, Florida, and India. (https://arxtlabs.com)
About 1606 Corp - Bridging Today and Tomorrow with Innovative
Technology
At 1606 Corp, we are not just a CBD company; we are a dynamic
think tank with innovative technology solutions that are aimed at
solving the top online customer service problems in the CBD
industry. Established as an acquisition-based company, CBDW AI has
developed a vision to redefine the CBD industry through both
acquisitions and technology development. 1606 Corp stands at the
intersection of cutting-edge technology and visionary
collaborations to help you, the CBD consumer. Our mission is clear
- to revolutionize the CBD industry by seamlessly integrating
technology into the core operations of all CBD companies in the
United States. We strive to empower businesses, both large and
small, with enterprise solutions that drive efficiency, foster
online sales growth, and open doors to unprecedented education and
usage by CBD customers.
Industry Information;
Rates of cannabidiol (CBD) usage in the United States are
projected to surge in 2023, according to Stirling CBD. With recent
studies suggesting as high as a 10% year-over-year (YoY) increase
in usage, Stirling CBD predicts that 2023 will be a pivotal year
for the industry as the widespread adoption of CBD-infused products
is set to take place across the health and wellness, beauty, and
food and beverage industries.
Data from 2022 provides insight into the widespread nature of
CBD-infused products. The Center for Advancing Health (CFAH)
reported that 26% of Americans used CBD in 2022, and according
to ClevelandClinic.org, 42% of people who take CBD use it
for sleep-related reasons. It is also often marketed toward
individuals struggling with anxiety, depression, quitting smoking,
fitness recovery, and post-traumatic stress disorder (PTSD).
Forward-Looking Statements
This press release contains statements that constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These statements
appear in a number of places in this release and include all
statements that are not statements of historical fact regarding the
intent, belief, or current expectations of 1606 Corp (the
"Company"), its directors, or its officers with respect to, among
other things: (i) financing plans; (ii) trends affecting its
financial condition or results of operations; (iii) growth strategy
and operating strategy. The words "may," "would," "will," "expect,"
"estimate," "can," "believe," "potential" and similar expressions
and variations thereof are intended to identify forward-looking
statements. Investors are cautioned that any such forward-looking
statements are not guarantees of future performance and involve
risks and uncertainties, many of which are beyond the Company's
ability to control, and actual results may differ materially from
those projected in the forward-looking statements as a result of
various factors. You should not place undue reliance on
forward-looking statements since they involve known and unknown
risks, uncertainties, and other factors, which are, in some cases,
beyond the Company's control and which could, and likely will
materially affect actual results, levels of activity, performance,
or achievements. The Company assumes no obligation to publicly
update or revise these forward-looking statements for any reason,
or to update the reasons actual results could differ materially
from those anticipated in these forward-looking statements, even if
new information becomes available in the future. Important factors
that could cause actual results to differ materially from the
company's expectations include but are not limited to, those
factors that are disclosed under the heading "Risk Factors" and
elsewhere in documents filed by the company from time to time with
the United States Securities and Exchange Commission and other
regulatory authorities.
SOURCE 1606 Corp
1606 (PK) (USOTC:CBDW)
Historical Stock Chart
From Apr 2024 to May 2024
1606 (PK) (USOTC:CBDW)
Historical Stock Chart
From May 2023 to May 2024